share_log

Doximity | 8-K: Doximity Announces Fiscal 2024 Third Quarter Financial Results

Doximity | 8-K:Doximity 公布2024财年第三季度财务业绩

SEC announcement ·  02/08 16:14
Moomoo AI 已提取核心信息
On February 8, 2024, Doximity, Inc., a leading digital platform for U.S. medical professionals, reported its financial results for the fiscal quarter ending December 31, 2023. The company announced a 17% year-over-year increase in revenue to $135.3 million, with net income growing by 43% to $48.0 million, resulting in a net income margin of 35%. Adjusted EBITDA also saw a significant increase of 32% compared to the previous year, reaching $73.3 million. Doximity's diluted net income per share rose from $0.16 to $0.24, and non-GAAP diluted net income per share increased from $0.22 to $0.29. The company's operating cash flow and free cash flow both experienced a 3% year-over-year increase. Looking ahead, Doximity provided guidance for its fiscal fourth quarter with revenue expected to be between $115.9 million and...Show More
On February 8, 2024, Doximity, Inc., a leading digital platform for U.S. medical professionals, reported its financial results for the fiscal quarter ending December 31, 2023. The company announced a 17% year-over-year increase in revenue to $135.3 million, with net income growing by 43% to $48.0 million, resulting in a net income margin of 35%. Adjusted EBITDA also saw a significant increase of 32% compared to the previous year, reaching $73.3 million. Doximity's diluted net income per share rose from $0.16 to $0.24, and non-GAAP diluted net income per share increased from $0.22 to $0.29. The company's operating cash flow and free cash flow both experienced a 3% year-over-year increase. Looking ahead, Doximity provided guidance for its fiscal fourth quarter with revenue expected to be between $115.9 million and $116.9 million, and adjusted EBITDA projected between $50.5 million and $51.5 million. The company also updated its full fiscal year guidance, anticipating revenues between $473.3 million and $474.3 million, and adjusted EBITDA between $224.5 million and $225.5 million. Doximity's CEO, Jeff Tangney, expressed pride in the company's double-digit engagement growth and the continued daily use of their clinical workflow tools by doctors. The company now serves 17 of the top 22 U.S. hospitals as enterprise software clients.
2024年2月8日,面向美国医疗专业人员的领先数字平台Doximity, Inc. 公布了截至2023年12月31日的财季财务业绩。该公司宣布收入同比增长17%,达到1.353亿美元,净收入增长43%,达到4,800万美元,净收入利润率为35%。调整后的息税折旧摊销前利润也比上年大幅增长了32%,达到7,330万美元。Doximity的摊薄后每股净收益从0.16美元增至0.24美元,非公认会计准则摊薄后的每股净收益从0.22美元增至0.29美元。该公司的运营现金流和自由现金流均同比增长3%。展望未来,Doximity为其第四财季提供了指导,收入预计在1.159亿美元至1.169亿美元之间,调整...展开全部
2024年2月8日,面向美国医疗专业人员的领先数字平台Doximity, Inc. 公布了截至2023年12月31日的财季财务业绩。该公司宣布收入同比增长17%,达到1.353亿美元,净收入增长43%,达到4,800万美元,净收入利润率为35%。调整后的息税折旧摊销前利润也比上年大幅增长了32%,达到7,330万美元。Doximity的摊薄后每股净收益从0.16美元增至0.24美元,非公认会计准则摊薄后的每股净收益从0.22美元增至0.29美元。该公司的运营现金流和自由现金流均同比增长3%。展望未来,Doximity为其第四财季提供了指导,收入预计在1.159亿美元至1.169亿美元之间,调整后的息税折旧摊销前利润预计在5,050万美元至5,150万美元之间。该公司还更新了完整的财年预期,预计收入在4.733亿美元至4.743亿美元之间,调整后的息税折旧摊销前利润在2.245亿美元至2.255亿美元之间。Doximity的首席执行官杰夫·坦尼对该公司的两位数参与度增长以及医生每天持续使用其临床工作流程工具表示自豪。该公司现在作为企业软件客户为美国排名前22位的医院中的17家提供服务。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息